Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug save search
Revolutionizing Therapeutics: The Next Generation Sequencing Boom in Global Drug R&D | BCC Research
Published: 2024-02-06 (Crawled : 15:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.16%
H: 1.45%
C: 1.41%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: 0.34%
H: 1.85%
C: 1.63%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -0.13%
H: 2.6%
C: 2.42%
drug research global
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
Published: 2024-02-06 (Crawled : 13:00) - globenewswire.com
SEER | $1.67 -4.57% -4.79% 670K
|
Professional, Scientific, and T...
|
| O: -0.6%
H: 7.23%
C: 6.63%
drug genetic biomarker
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024
Published: 2024-02-05 (Crawled : 18:00) - biospace.com/
BRKR | $77.725 -1.06% -1.07% 1.3M
|
Health Technology
|
| O: -0.4%
H: 0.82%
C: -0.08%
slas2024 drug system
Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms
Published: 2024-02-05 (Crawled : 15:00) - biospace.com/
AIMD | $1.03 1.92% 21K
|
Manufacturing
|
| O: 11.65%
H: 0.0%
C: -6.09%
covid-19 fda drug resolve trial response
Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development
Published: 2024-02-05 (Crawled : 12:30) - prnewswire.com
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: 0.16%
H: 0.35%
C: -0.62%
drug hospital collaboration medical
Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition
Published: 2024-02-05 (Crawled : 12:30) - globenewswire.com
VRCA | $6.96 0.87% 0.72% 130K
|
Health Technology
|
| O: -0.88%
H: 0.09%
C: -6.76%
drug pharmaceuticals
BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Published: 2024-02-05 (Crawled : 12:30) - bridgebio.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -1.21%
H: 1.43%
C: 0.39%
pharma drug food treatment application
Drug Pricing Reforms Front and Center as 2024 Election Ramps Up
Published: 2024-02-02 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
drug
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
Published: 2024-02-01 (Crawled : 22:00) - globenewswire.com
CABA | $13.31 -4.72% -4.96% 1.2M
|
Health Technology
|
| O: -2.09%
H: 12.16%
C: 9.33%
caba-201 fda drug granted treatment designation
Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published: 2024-02-01 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.29%
H: 0.0%
C: -1.38%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.07%
H: 0.83%
C: 0.7%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.55%
H: 0.79%
C: 0.25%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.27%
H: 1.87%
C: 1.73%
EMN | $96.42 0.42% 0.0% 700K
|
Process Industries
|
| O: 0.79%
H: 0.8%
C: 0.77%
drug expansion global growing
AstraZeneca Case Leads Off Busy Year of Challenges to Medicare Drug Pricing Law
Published: 2024-02-01 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
drug year astrazeneca
National Tay-Sachs & Allied Diseases Association Hosts First of Its Kind Drug Development Meeting for GM2
Published: 2024-02-01 (Crawled : 14:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
first drug association meeting
Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
Published: 2024-02-01 (Crawled : 12:00) - globenewswire.com
SCTL | $1.1 -0.91% 510K
|
Manufacturing
|
| O: 0.36%
H: 29.49%
C: 21.96%
drug services agreement
NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline
Published: 2024-02-01 (Crawled : 09:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -0.86%
H: 3.34%
C: 0.43%
drug pipeline series extension
Global Respiratory Drug Delivery Market Report 2024 - A US$67 Billion Market - Trends in Metered Dose Inhaler (MDI) Technology to Propel the Market
Published: 2024-01-31 (Crawled : 17:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -0.09%
H: 0.93%
C: -1.31%
drug propel report respiratory global trends technology market
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis
Published: 2024-01-31 (Crawled : 14:30) - biospace.com/
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 1.37%
H: 1.35%
C: -2.7%
vtr-297 fda drug candidate approval treatment pharmaceuticals antifungal
Astellas Submits Supplemental New Drug Application in Japan for PADCEV™ (enfortumab vedotin (genetical recombination)) with KEYTRUDA® (pembrolizumab (genetical recombination)) for First-Line Treatment of Advanced Bladder Cancer
Published: 2024-01-31 (Crawled : 02:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: 4.34%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 0.0%
H: 1.38%
C: 0.26%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.56%
H: 1.25%
C: -0.33%
keytruda drug japan bladder cancer treatment application advanced
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
PBYI | $5.01 0.4% 0.4% 290K
|
Health Technology
|
| O: -0.1%
H: 2.31%
C: -1.26%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.44%
H: 0.2%
C: -0.55%
drug breast expected cancer pipeline therapeutics growth market
Fingerprint Drug Test Delivers Quantifiable Benefits for Customers as Adoption in Workplaces Accelerates
Published: 2024-01-30 (Crawled : 14:00) - globenewswire.com
INBS | $2.71 -3.21% -3.32% 58K
|
Manufacturing
|
| O: -0.96%
H: 3.23%
C: -10.32%
drug test workplaces benefits
Leading UK Timber Processor and Packaging Manufacturer, James Jones & Sons Ltd., Adopts Intelligent Bio Solutions’ Fingerprint Drug Screening System Across its 25 Sites and 1,300 Employees
Published: 2024-01-29 (Crawled : 14:00) - globenewswire.com
INBS | $2.71 -3.21% -3.32% 58K
|
Manufacturing
|
| O: 10.97%
H: 32.02%
C: 7.33%
drug jones system
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.